This week, we Zoom On Alberico L. Catapano, who has dedicated his career to investigating the causes of atherosclerosis as they relate to biochemistry and genetics, and to designing clinical trials which explore the efficacy of lipid-lowering and anti-atherosclerotic drugs. He is active in both Italian and international societies, including the European Atherosclerosis Society (EAS).
Prof. Catapano is a Full Professor of Pharmacology in the Department of Pharmacological Sciences at the University of Milan, Italy. He is also Director of the Laboratory of Lipoprotein Metabolism at the Center for the Study of Atherosclerosis at Bassini Hospital in Milan, where his research deals with the cellular metabolism of lipoproteins and molecular defects in atherogenesis. In addition to those roles, he also directs the Centre for Pharmacoepidemiology and Pharmacoutilisation. Five different Italian universities are involved at the centre, which is focused on cardiovascular research at the MultiMedica IRCSS, also in Milan.
Within Italy, Prof. Catapano has played a number of distinguished roles. He has served as President of both the Italian Society for Clinical and Experimental Therapy (SITeCS) and the Italian Society for the Study of Atherosclerosis (Lombardy chapter). With the Italian Society of Cardiology, he coordinates the group that specialises in arteriosclerosis, thrombosis and vascular biology.
Beyond the Italian borders, Prof. Catapano is an International Society of Atherosclerosis Distinguished Fellow. He has organised international meetings and served as scientific secretary of the DALM. He is a professional member of the American Heart Association (AHA).
His affiliation with the EAS is longstanding; he has been a member of the Executive Committee since 2008 and has been a co-chair of the group which prepared and published the 2011 Joint Guidelines on Management of Dyslipidemia. Those guidelines blended input from both the EAS and the European Society of Cardiology (ESC). The same year, he organised the EAS Advanced Course in Clinical Lipidology in Milan. In 2012, he chaired the 80th EAS Congress in the same city.
A 1975 graduate from the University of Milan, Prof. Catapano received his PhD in 1979. He has published more than 300 papers in peer-reviewed journals on the topics of basic and clinical lipidology. Prof. Catapano is an editorial board member of multiple journals, and is the current editor for supplements to Atherosclerosis. He has served as editor of 12 books about atherosclerosis, lipids and lipoprotein metabolism.
Sources: The European Atherosclerosis Society (EAS); Radcliffe Cardiology
Image Credit: EAS